The global market for Non-Invasive Liquid Biopsy was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Non-invasive liquid biopsy is to analyze and diagnose diseases such as cancer through blood or urine and other body fluids. At present, the main application area of liquid biopsy is the blood detection of tumors, that is, the use of blood to indicate tumor development and drug resistance and other information to guide individualized and precise treatment. Compared with existing tumor detection methods, liquid biopsy is non-invasive, can be detected frequently and repeatedly, and has rapid response capabilities. It has significant advantages and has great potential for application development.

North American market for Non-Invasive Liquid Biopsy is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Non-Invasive Liquid Biopsy is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for Non-Invasive Liquid Biopsy in Hospital is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Non-Invasive Liquid Biopsy include Bio-Techne, Endress+Hauser, Exact Sciences Corporation, Lonza Group AG, MDxHealth, Merck KGaA, MutantDx, Norgen Biotek Corp, Nucleix, Oasis Diagnostics Corporation, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Non-Invasive Liquid Biopsy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Non-Invasive Liquid Biopsy.

The Non-Invasive Liquid Biopsy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Non-Invasive Liquid Biopsy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Non-Invasive Liquid Biopsy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Non-Invasive Liquid Biopsy Market Report

Report Metric	Details
Report Name	Non-Invasive Liquid Biopsy Market
Segment by Type	Stool Test Urine Test Saliva Test Others
Segment by Application	Hospital Laboratory Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Bio-Techne, Endress+Hauser, Exact Sciences Corporation, Lonza Group AG, MDxHealth, Merck KGaA, MutantDx, Norgen Biotek Corp, Nucleix, Oasis Diagnostics Corporation, OraSure Technologies, PerkinElmer, Predicine, Qiagen, Thermo Fisher Scientific, Zymo Research Corporation
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Non-Invasive Liquid Biopsy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Non-Invasive Liquid Biopsy Market report?

Ans: The main players in the Non-Invasive Liquid Biopsy Market are Bio-Techne, Endress+Hauser, Exact Sciences Corporation, Lonza Group AG, MDxHealth, Merck KGaA, MutantDx, Norgen Biotek Corp, Nucleix, Oasis Diagnostics Corporation, OraSure Technologies, PerkinElmer, Predicine, Qiagen, Thermo Fisher Scientific, Zymo Research Corporation

What are the Application segmentation covered in the Non-Invasive Liquid Biopsy Market report?

Ans: The Applications covered in the Non-Invasive Liquid Biopsy Market report are Hospital, Laboratory, Others

What are the Type segmentation covered in the Non-Invasive Liquid Biopsy Market report?

Ans: The Types covered in the Non-Invasive Liquid Biopsy Market report are Stool Test, Urine Test, Saliva Test, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Non-Invasive Liquid Biopsy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Stool Test

1.2.3 Urine Test

1.2.4 Saliva Test

1.2.5 Others

1.3 Market by Application

1.3.1 Global Non-Invasive Liquid Biopsy Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospital

1.3.3 Laboratory

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Non-Invasive Liquid Biopsy Market Perspective (2020-2031)

2.2 Global Non-Invasive Liquid Biopsy Growth Trends by Region

2.2.1 Global Non-Invasive Liquid Biopsy Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Non-Invasive Liquid Biopsy Historic Market Size by Region (2020-2025)

2.2.3 Non-Invasive Liquid Biopsy Forecasted Market Size by Region (2026-2031)

2.3 Non-Invasive Liquid Biopsy Market Dynamics

2.3.1 Non-Invasive Liquid Biopsy Industry Trends

2.3.2 Non-Invasive Liquid Biopsy Market Drivers

2.3.3 Non-Invasive Liquid Biopsy Market Challenges

2.3.4 Non-Invasive Liquid Biopsy Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Non-Invasive Liquid Biopsy Players by Revenue

3.1.1 Global Top Non-Invasive Liquid Biopsy Players by Revenue (2020-2025)

3.1.2 Global Non-Invasive Liquid Biopsy Revenue Market Share by Players (2020-2025)

3.2 Global Non-Invasive Liquid Biopsy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Non-Invasive Liquid Biopsy Revenue

3.4 Global Non-Invasive Liquid Biopsy Market Concentration Ratio

3.4.1 Global Non-Invasive Liquid Biopsy Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Non-Invasive Liquid Biopsy Revenue in 2024

3.5 Global Key Players of Non-Invasive Liquid Biopsy Head office and Area Served

3.6 Global Key Players of Non-Invasive Liquid Biopsy, Product and Application

3.7 Global Key Players of Non-Invasive Liquid Biopsy, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Non-Invasive Liquid Biopsy Breakdown Data by Type

4.1 Global Non-Invasive Liquid Biopsy Historic Market Size by Type (2020-2025)

4.2 Global Non-Invasive Liquid Biopsy Forecasted Market Size by Type (2026-2031)

5 Non-Invasive Liquid Biopsy Breakdown Data by Application

5.1 Global Non-Invasive Liquid Biopsy Historic Market Size by Application (2020-2025)

5.2 Global Non-Invasive Liquid Biopsy Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Non-Invasive Liquid Biopsy Market Size (2020-2031)

6.2 North America Non-Invasive Liquid Biopsy Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Non-Invasive Liquid Biopsy Market Size by Country (2020-2025)

6.4 North America Non-Invasive Liquid Biopsy Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Non-Invasive Liquid Biopsy Market Size (2020-2031)

7.2 Europe Non-Invasive Liquid Biopsy Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Non-Invasive Liquid Biopsy Market Size by Country (2020-2025)

7.4 Europe Non-Invasive Liquid Biopsy Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Non-Invasive Liquid Biopsy Market Size (2020-2031)

8.2 Asia-Pacific Non-Invasive Liquid Biopsy Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Non-Invasive Liquid Biopsy Market Size by Region (2020-2025)

8.4 Asia-Pacific Non-Invasive Liquid Biopsy Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Non-Invasive Liquid Biopsy Market Size (2020-2031)

9.2 Latin America Non-Invasive Liquid Biopsy Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Non-Invasive Liquid Biopsy Market Size by Country (2020-2025)

9.4 Latin America Non-Invasive Liquid Biopsy Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Non-Invasive Liquid Biopsy Market Size (2020-2031)

10.2 Middle East & Africa Non-Invasive Liquid Biopsy Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Non-Invasive Liquid Biopsy Market Size by Country (2020-2025)

10.4 Middle East & Africa Non-Invasive Liquid Biopsy Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Bio-Techne

11.1.1 Bio-Techne Company Details

11.1.2 Bio-Techne Business Overview

11.1.3 Bio-Techne Non-Invasive Liquid Biopsy Introduction

11.1.4 Bio-Techne Revenue in Non-Invasive Liquid Biopsy Business (2020-2025)

11.1.5 Bio-Techne Recent Development

11.2 Endress+Hauser

11.2.1 Endress+Hauser Company Details

11.2.2 Endress+Hauser Business Overview

11.2.3 Endress+Hauser Non-Invasive Liquid Biopsy Introduction

11.2.4 Endress+Hauser Revenue in Non-Invasive Liquid Biopsy Business (2020-2025)

11.2.5 Endress+Hauser Recent Development

11.3 Exact Sciences Corporation

11.3.1 Exact Sciences Corporation Company Details

11.3.2 Exact Sciences Corporation Business Overview

11.3.3 Exact Sciences Corporation Non-Invasive Liquid Biopsy Introduction

11.3.4 Exact Sciences Corporation Revenue in Non-Invasive Liquid Biopsy Business (2020-2025)

11.3.5 Exact Sciences Corporation Recent Development

11.4 Lonza Group AG

11.4.1 Lonza Group AG Company Details

11.4.2 Lonza Group AG Business Overview

11.4.3 Lonza Group AG Non-Invasive Liquid Biopsy Introduction

11.4.4 Lonza Group AG Revenue in Non-Invasive Liquid Biopsy Business (2020-2025)

11.4.5 Lonza Group AG Recent Development

11.5 MDxHealth

11.5.1 MDxHealth Company Details

11.5.2 MDxHealth Business Overview

11.5.3 MDxHealth Non-Invasive Liquid Biopsy Introduction

11.5.4 MDxHealth Revenue in Non-Invasive Liquid Biopsy Business (2020-2025)

11.5.5 MDxHealth Recent Development

11.6 Merck KGaA

11.6.1 Merck KGaA Company Details

11.6.2 Merck KGaA Business Overview

11.6.3 Merck KGaA Non-Invasive Liquid Biopsy Introduction

11.6.4 Merck KGaA Revenue in Non-Invasive Liquid Biopsy Business (2020-2025)

11.6.5 Merck KGaA Recent Development

11.7 MutantDx

11.7.1 MutantDx Company Details

11.7.2 MutantDx Business Overview

11.7.3 MutantDx Non-Invasive Liquid Biopsy Introduction

11.7.4 MutantDx Revenue in Non-Invasive Liquid Biopsy Business (2020-2025)

11.7.5 MutantDx Recent Development

11.8 Norgen Biotek Corp

11.8.1 Norgen Biotek Corp Company Details

11.8.2 Norgen Biotek Corp Business Overview

11.8.3 Norgen Biotek Corp Non-Invasive Liquid Biopsy Introduction

11.8.4 Norgen Biotek Corp Revenue in Non-Invasive Liquid Biopsy Business (2020-2025)

11.8.5 Norgen Biotek Corp Recent Development

11.9 Nucleix

11.9.1 Nucleix Company Details

11.9.2 Nucleix Business Overview

11.9.3 Nucleix Non-Invasive Liquid Biopsy Introduction

11.9.4 Nucleix Revenue in Non-Invasive Liquid Biopsy Business (2020-2025)

11.9.5 Nucleix Recent Development

11.10 Oasis Diagnostics Corporation

11.10.1 Oasis Diagnostics Corporation Company Details

11.10.2 Oasis Diagnostics Corporation Business Overview

11.10.3 Oasis Diagnostics Corporation Non-Invasive Liquid Biopsy Introduction

11.10.4 Oasis Diagnostics Corporation Revenue in Non-Invasive Liquid Biopsy Business (2020-2025)

11.10.5 Oasis Diagnostics Corporation Recent Development

11.11 OraSure Technologies

11.11.1 OraSure Technologies Company Details

11.11.2 OraSure Technologies Business Overview

11.11.3 OraSure Technologies Non-Invasive Liquid Biopsy Introduction

11.11.4 OraSure Technologies Revenue in Non-Invasive Liquid Biopsy Business (2020-2025)

11.11.5 OraSure Technologies Recent Development

11.12 PerkinElmer

11.12.1 PerkinElmer Company Details

11.12.2 PerkinElmer Business Overview

11.12.3 PerkinElmer Non-Invasive Liquid Biopsy Introduction

11.12.4 PerkinElmer Revenue in Non-Invasive Liquid Biopsy Business (2020-2025)

11.12.5 PerkinElmer Recent Development

11.13 Predicine

11.13.1 Predicine Company Details

11.13.2 Predicine Business Overview

11.13.3 Predicine Non-Invasive Liquid Biopsy Introduction

11.13.4 Predicine Revenue in Non-Invasive Liquid Biopsy Business (2020-2025)

11.13.5 Predicine Recent Development

11.14 Qiagen

11.14.1 Qiagen Company Details

11.14.2 Qiagen Business Overview

11.14.3 Qiagen Non-Invasive Liquid Biopsy Introduction

11.14.4 Qiagen Revenue in Non-Invasive Liquid Biopsy Business (2020-2025)

11.14.5 Qiagen Recent Development

11.15 Thermo Fisher Scientific

11.15.1 Thermo Fisher Scientific Company Details

11.15.2 Thermo Fisher Scientific Business Overview

11.15.3 Thermo Fisher Scientific Non-Invasive Liquid Biopsy Introduction

11.15.4 Thermo Fisher Scientific Revenue in Non-Invasive Liquid Biopsy Business (2020-2025)

11.15.5 Thermo Fisher Scientific Recent Development

11.16 Zymo Research Corporation

11.16.1 Zymo Research Corporation Company Details

11.16.2 Zymo Research Corporation Business Overview

11.16.3 Zymo Research Corporation Non-Invasive Liquid Biopsy Introduction

11.16.4 Zymo Research Corporation Revenue in Non-Invasive Liquid Biopsy Business (2020-2025)

11.16.5 Zymo Research Corporation Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Bio-Techne

Endress+Hauser

Exact Sciences Corporation

Oasis Diagnostics Corporation

Thermo Fisher Scientific

Zymo Research Corporation

List of Tables

Table 1. Global Non-Invasive Liquid Biopsy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Stool Test

Table 3. Key Players of Urine Test

Table 4. Key Players of Saliva Test

Table 5. Key Players of Others

Table 6. Global Non-Invasive Liquid Biopsy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Non-Invasive Liquid Biopsy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Non-Invasive Liquid Biopsy Market Size by Region (2020-2025) & (US$ Million)

Table 9. Global Non-Invasive Liquid Biopsy Market Share by Region (2020-2025)

Table 10. Global Non-Invasive Liquid Biopsy Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 11. Global Non-Invasive Liquid Biopsy Market Share by Region (2026-2031)

Table 12. Non-Invasive Liquid Biopsy Market Trends

Table 13. Non-Invasive Liquid Biopsy Market Drivers

Table 14. Non-Invasive Liquid Biopsy Market Challenges

Table 15. Non-Invasive Liquid Biopsy Market Restraints

Table 16. Global Non-Invasive Liquid Biopsy Revenue by Players (2020-2025) & (US$ Million)

Table 17. Global Non-Invasive Liquid Biopsy Market Share by Players (2020-2025)

Table 18. Global Top Non-Invasive Liquid Biopsy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-Invasive Liquid Biopsy as of 2024)

Table 19. Ranking of Global Top Non-Invasive Liquid Biopsy Companies by Revenue (US$ Million) in 2024

Table 20. Global 5 Largest Players Market Share by Non-Invasive Liquid Biopsy Revenue (CR5 and HHI) & (2020-2025)

Table 21. Global Key Players of Non-Invasive Liquid Biopsy, Headquarters and Area Served

Table 22. Global Key Players of Non-Invasive Liquid Biopsy, Product and Application

Table 23. Global Key Players of Non-Invasive Liquid Biopsy, Date of Enter into This Industry

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Non-Invasive Liquid Biopsy Market Size by Type (2020-2025) & (US$ Million)

Table 26. Global Non-Invasive Liquid Biopsy Revenue Market Share by Type (2020-2025)

Table 27. Global Non-Invasive Liquid Biopsy Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 28. Global Non-Invasive Liquid Biopsy Revenue Market Share by Type (2026-2031)

Table 29. Global Non-Invasive Liquid Biopsy Market Size by Application (2020-2025) & (US$ Million)

Table 30. Global Non-Invasive Liquid Biopsy Revenue Market Share by Application (2020-2025)

Table 31. Global Non-Invasive Liquid Biopsy Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 32. Global Non-Invasive Liquid Biopsy Revenue Market Share by Application (2026-2031)

Table 33. North America Non-Invasive Liquid Biopsy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 34. North America Non-Invasive Liquid Biopsy Market Size by Country (2020-2025) & (US$ Million)

Table 35. North America Non-Invasive Liquid Biopsy Market Size by Country (2026-2031) & (US$ Million)

Table 36. Europe Non-Invasive Liquid Biopsy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. Europe Non-Invasive Liquid Biopsy Market Size by Country (2020-2025) & (US$ Million)

Table 38. Europe Non-Invasive Liquid Biopsy Market Size by Country (2026-2031) & (US$ Million)

Table 39. Asia-Pacific Non-Invasive Liquid Biopsy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 40. Asia-Pacific Non-Invasive Liquid Biopsy Market Size by Region (2020-2025) & (US$ Million)

Table 41. Asia-Pacific Non-Invasive Liquid Biopsy Market Size by Region (2026-2031) & (US$ Million)

Table 42. Latin America Non-Invasive Liquid Biopsy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 43. Latin America Non-Invasive Liquid Biopsy Market Size by Country (2020-2025) & (US$ Million)

Table 44. Latin America Non-Invasive Liquid Biopsy Market Size by Country (2026-2031) & (US$ Million)

Table 45. Middle East & Africa Non-Invasive Liquid Biopsy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Middle East & Africa Non-Invasive Liquid Biopsy Market Size by Country (2020-2025) & (US$ Million)

Table 47. Middle East & Africa Non-Invasive Liquid Biopsy Market Size by Country (2026-2031) & (US$ Million)

Table 48. Bio-Techne Company Details

Table 49. Bio-Techne Business Overview

Table 50. Bio-Techne Non-Invasive Liquid Biopsy Product

Table 51. Bio-Techne Revenue in Non-Invasive Liquid Biopsy Business (2020-2025) & (US$ Million)

Table 52. Bio-Techne Recent Development

Table 53. Endress+Hauser Company Details

Table 54. Endress+Hauser Business Overview

Table 55. Endress+Hauser Non-Invasive Liquid Biopsy Product

Table 56. Endress+Hauser Revenue in Non-Invasive Liquid Biopsy Business (2020-2025) & (US$ Million)

Table 57. Endress+Hauser Recent Development

Table 58. Exact Sciences Corporation Company Details

Table 59. Exact Sciences Corporation Business Overview

Table 60. Exact Sciences Corporation Non-Invasive Liquid Biopsy Product

Table 61. Exact Sciences Corporation Revenue in Non-Invasive Liquid Biopsy Business (2020-2025) & (US$ Million)

Table 62. Exact Sciences Corporation Recent Development

Table 63. Lonza Group AG Company Details

Table 64. Lonza Group AG Business Overview

Table 65. Lonza Group AG Non-Invasive Liquid Biopsy Product

Table 66. Lonza Group AG Revenue in Non-Invasive Liquid Biopsy Business (2020-2025) & (US$ Million)

Table 67. Lonza Group AG Recent Development

Table 68. MDxHealth Company Details

Table 69. MDxHealth Business Overview

Table 70. MDxHealth Non-Invasive Liquid Biopsy Product

Table 71. MDxHealth Revenue in Non-Invasive Liquid Biopsy Business (2020-2025) & (US$ Million)

Table 72. MDxHealth Recent Development

Table 73. Merck KGaA Company Details

Table 74. Merck KGaA Business Overview

Table 75. Merck KGaA Non-Invasive Liquid Biopsy Product

Table 76. Merck KGaA Revenue in Non-Invasive Liquid Biopsy Business (2020-2025) & (US$ Million)

Table 77. Merck KGaA Recent Development

Table 78. MutantDx Company Details

Table 79. MutantDx Business Overview

Table 80. MutantDx Non-Invasive Liquid Biopsy Product

Table 81. MutantDx Revenue in Non-Invasive Liquid Biopsy Business (2020-2025) & (US$ Million)

Table 82. MutantDx Recent Development

Table 83. Norgen Biotek Corp Company Details

Table 84. Norgen Biotek Corp Business Overview

Table 85. Norgen Biotek Corp Non-Invasive Liquid Biopsy Product

Table 86. Norgen Biotek Corp Revenue in Non-Invasive Liquid Biopsy Business (2020-2025) & (US$ Million)

Table 87. Norgen Biotek Corp Recent Development

Table 88. Nucleix Company Details

Table 89. Nucleix Business Overview

Table 90. Nucleix Non-Invasive Liquid Biopsy Product

Table 91. Nucleix Revenue in Non-Invasive Liquid Biopsy Business (2020-2025) & (US$ Million)

Table 92. Nucleix Recent Development

Table 93. Oasis Diagnostics Corporation Company Details

Table 94. Oasis Diagnostics Corporation Business Overview

Table 95. Oasis Diagnostics Corporation Non-Invasive Liquid Biopsy Product

Table 96. Oasis Diagnostics Corporation Revenue in Non-Invasive Liquid Biopsy Business (2020-2025) & (US$ Million)

Table 97. Oasis Diagnostics Corporation Recent Development

Table 98. OraSure Technologies Company Details

Table 99. OraSure Technologies Business Overview

Table 100. OraSure Technologies Non-Invasive Liquid Biopsy Product

Table 101. OraSure Technologies Revenue in Non-Invasive Liquid Biopsy Business (2020-2025) & (US$ Million)

Table 102. OraSure Technologies Recent Development

Table 103. PerkinElmer Company Details

Table 104. PerkinElmer Business Overview

Table 105. PerkinElmer Non-Invasive Liquid Biopsy Product

Table 106. PerkinElmer Revenue in Non-Invasive Liquid Biopsy Business (2020-2025) & (US$ Million)

Table 107. PerkinElmer Recent Development

Table 108. Predicine Company Details

Table 109. Predicine Business Overview

Table 110. Predicine Non-Invasive Liquid Biopsy Product

Table 111. Predicine Revenue in Non-Invasive Liquid Biopsy Business (2020-2025) & (US$ Million)

Table 112. Predicine Recent Development

Table 113. Qiagen Company Details

Table 114. Qiagen Business Overview

Table 115. Qiagen Non-Invasive Liquid Biopsy Product

Table 116. Qiagen Revenue in Non-Invasive Liquid Biopsy Business (2020-2025) & (US$ Million)

Table 117. Qiagen Recent Development

Table 118. Thermo Fisher Scientific Company Details

Table 119. Thermo Fisher Scientific Business Overview

Table 120. Thermo Fisher Scientific Non-Invasive Liquid Biopsy Product

Table 121. Thermo Fisher Scientific Revenue in Non-Invasive Liquid Biopsy Business (2020-2025) & (US$ Million)

Table 122. Thermo Fisher Scientific Recent Development

Table 123. Zymo Research Corporation Company Details

Table 124. Zymo Research Corporation Business Overview

Table 125. Zymo Research Corporation Non-Invasive Liquid Biopsy Product

Table 126. Zymo Research Corporation Revenue in Non-Invasive Liquid Biopsy Business (2020-2025) & (US$ Million)

Table 127. Zymo Research Corporation Recent Development

Table 128. Research Programs/Design for This Report

Table 129. Key Data Information from Secondary Sources

Table 130. Key Data Information from Primary Sources

Table 131. Authors List of This Report

List of Figures

Figure 1. Non-Invasive Liquid Biopsy Picture

Figure 2. Global Non-Invasive Liquid Biopsy Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Non-Invasive Liquid Biopsy Market Share by Type: 2024 VS 2031

Figure 4. Stool Test Features

Figure 5. Urine Test Features

Figure 6. Saliva Test Features

Figure 7. Others Features

Figure 8. Global Non-Invasive Liquid Biopsy Market Size by Application (2020-2031) & (US$ Million)

Figure 9. Global Non-Invasive Liquid Biopsy Market Share by Application: 2024 VS 2031

Figure 10. Hospital Case Studies

Figure 11. Laboratory Case Studies

Figure 12. Others Case Studies

Figure 13. Non-Invasive Liquid Biopsy Report Years Considered

Figure 14. Global Non-Invasive Liquid Biopsy Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 15. Global Non-Invasive Liquid Biopsy Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 16. Global Non-Invasive Liquid Biopsy Market Share by Region: 2024 VS 2031

Figure 17. Global Non-Invasive Liquid Biopsy Market Share by Players in 2024

Figure 18. Global Top Non-Invasive Liquid Biopsy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-Invasive Liquid Biopsy as of 2024)

Figure 19. The Top 10 and 5 Players Market Share by Non-Invasive Liquid Biopsy Revenue in 2024

Figure 20. North America Non-Invasive Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. North America Non-Invasive Liquid Biopsy Market Share by Country (2020-2031)

Figure 22. United States Non-Invasive Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Canada Non-Invasive Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Non-Invasive Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Non-Invasive Liquid Biopsy Market Share by Country (2020-2031)

Figure 26. Germany Non-Invasive Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. France Non-Invasive Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. U.K. Non-Invasive Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Italy Non-Invasive Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Russia Non-Invasive Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Nordic Countries Non-Invasive Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Non-Invasive Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Non-Invasive Liquid Biopsy Market Share by Region (2020-2031)

Figure 34. China Non-Invasive Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Japan Non-Invasive Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. South Korea Non-Invasive Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Southeast Asia Non-Invasive Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. India Non-Invasive Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Australia Non-Invasive Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Non-Invasive Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Non-Invasive Liquid Biopsy Market Share by Country (2020-2031)

Figure 42. Mexico Non-Invasive Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Brazil Non-Invasive Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Non-Invasive Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Non-Invasive Liquid Biopsy Market Share by Country (2020-2031)

Figure 46. Turkey Non-Invasive Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Saudi Arabia Non-Invasive Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. UAE Non-Invasive Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Bio-Techne Revenue Growth Rate in Non-Invasive Liquid Biopsy Business (2020-2025)

Figure 50. Endress+Hauser Revenue Growth Rate in Non-Invasive Liquid Biopsy Business (2020-2025)

Figure 51. Exact Sciences Corporation Revenue Growth Rate in Non-Invasive Liquid Biopsy Business (2020-2025)

Figure 52. Lonza Group AG Revenue Growth Rate in Non-Invasive Liquid Biopsy Business (2020-2025)

Figure 53. MDxHealth Revenue Growth Rate in Non-Invasive Liquid Biopsy Business (2020-2025)

Figure 54. Merck KGaA Revenue Growth Rate in Non-Invasive Liquid Biopsy Business (2020-2025)

Figure 55. MutantDx Revenue Growth Rate in Non-Invasive Liquid Biopsy Business (2020-2025)

Figure 56. Norgen Biotek Corp Revenue Growth Rate in Non-Invasive Liquid Biopsy Business (2020-2025)

Figure 57. Nucleix Revenue Growth Rate in Non-Invasive Liquid Biopsy Business (2020-2025)

Figure 58. Oasis Diagnostics Corporation Revenue Growth Rate in Non-Invasive Liquid Biopsy Business (2020-2025)

Figure 59. OraSure Technologies Revenue Growth Rate in Non-Invasive Liquid Biopsy Business (2020-2025)

Figure 60. PerkinElmer Revenue Growth Rate in Non-Invasive Liquid Biopsy Business (2020-2025)

Figure 61. Predicine Revenue Growth Rate in Non-Invasive Liquid Biopsy Business (2020-2025)

Figure 62. Qiagen Revenue Growth Rate in Non-Invasive Liquid Biopsy Business (2020-2025)

Figure 63. Thermo Fisher Scientific Revenue Growth Rate in Non-Invasive Liquid Biopsy Business (2020-2025)

Figure 64. Zymo Research Corporation Revenue Growth Rate in Non-Invasive Liquid Biopsy Business (2020-2025)

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

Figure 67. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions